It can be looked at separately from what I was hearing. Hopefully only post-approval studies. AZN has a ton of data from all their trials backing safety and why they should only need post-approval studies. Also, seemed like the reviewers were concerned about withdrawal. AZN-NKTR may have an advantage here, for various reasons.
Look at what can possibly happen for VTUS. ZLCS soaring on data from Epirus!
VTUS, you stanky thing, time to ZOOM!!
Hepatitis is HOT. VTUS will have a pipeline compound in Hep B with the marriage with Assembly. Hepatitis Hypnosis Hypothesis Higher Highs Honest
LOL, did you see a BIG is after this right now. Biting down on it for 1.39, NICE! Coily, are you smoking MJMD with Greeny? They have some pot oil drugs that everybody loves so much. Mayor Ford wants them for himself to dance and sing in court with. Beav saw him live. I think Beav sells tickets to the Mayor Ford show. The mayor doesn't know why so many critters keep piling in to watch. Beav is quite a promoter. See you at the still atop the barge bridge.
We don't like it. Are you the famous rick from SNTS, if so, I might listen. He said buy ACHN, and I won a few months cat condo rent off that one 4-5 months ago.
Liar pants. Nobody reads this stuff, did they interogate the FDA? I would pay for that report.
LOL, now are you going to delete this before Freddy sees it. It is a cool way to send a message and then delete after the other person replies. Over and Out, Coily, I am coming over to the Green Room at toddy time.
Well, the merged company will be in the hot Hep space. Yes the shares should increase, it may be a nice entry but you will have to decide and who knows for sure about FDA meeting. If that is good longs stand to gain nicely.